Status:

COMPLETED

Tactile Electrosurgical Ablation in Cases of Dysfunctional Uterine Bleeding

Lead Sponsor:

Mostafa Hussein

Collaborating Sponsors:

Assiut University

Conditions:

Dysfunction Uterine Bleeding

Eligibility:

FEMALE

40-50 years

Phase:

PHASE2

Brief Summary

Abnormal uterine bleeding (AUB) is any alteration in the pattern or volume of menstrual blood flow and heavy menstrual bleeding affects up to 30% of women at some time during their reproductive years. ...

Eligibility Criteria

Inclusion

  • Patients with dysfunctional uterine bleeding aged between 40 to 50 years
  • Unsuccessful medical treatment.
  • No intrauterine abnormalities.
  • Endometrial biopsy negative for atypia and cancer.
  • follicle stimulating hormone level not exceeds 30 mills-International unit
  • Family complete
  • Patients who are not candidate for hysterectomy because of medical or surgical risks.

Exclusion

  • Coexisting gynecological pathology (e.g. uterovaginal prolapsed, ovarian pathology, pelvic inflammatory disease, cervical atypia).
  • Endometrial hyperplasia with atypia and cancer..
  • History or evidence of malignancy.
  • Hyperplasia in the endometrial biopsy.
  • Uterine size more than 12 weeks in size.
  • Women with caesarean or myomectomy scar

Key Trial Info

Start Date :

April 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2014

Estimated Enrollment :

108 Patients enrolled

Trial Details

Trial ID

NCT02248194

Start Date

April 1 2010

End Date

December 1 2014

Last Update

January 1 2016

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Woman's Health Hospital-Assiut University.

Asyut, Egypt